Delivery Order SPE2DB25D3002-SPE2DB25FLRLQ
- Not listed
- The Defense Logistics Agency's Medical Supply Chain awarded a $17,214.42 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Lupron Depot-Ped 15 mg kits on August 21, 2025, with an ultimate completion date of August 22, 2025. This non-set-aside award was made competitively and represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The products will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,911.29 to AmerisourceBergen Drug Corp for the supply of Lupron Depot-Ped 11.25 mg kits. This is a firm fixed price, competitively awarded contract with no set-aside designation, with an ultimate completion date of August 26, 2025. The delivery order will be fulfilled from AmerisourceBergen's Corporate Office located in Conshohocken, Pennsylvania. This award represents a child contract under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $14,215.44 for Lupron Depot-Ped 11.25 mg kits on September 8, 2025, with completion scheduled for September 9, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and was issued by the Defense Logistics Agency's Medical Supply Chain. The award leverages AmerisourceBergen's existing Indefinite Delivery...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $11,154.18 for Lupron Depot-Ped 11.25 mg (a 3-month supply) on September 3, 2025, with ultimate completion by September 4, 2025. This non-set-aside, competitively awarded contract with firm fixed pricing is funded through the Defense Logistics Agency's Medical Supply Chain and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Lupron Depot-Ped 15 mg kits valued at $2,609.47. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor. The contract is scheduled for ultimate completion on September 18, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $2,587.15 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Lupron Depot-Ped 11.25 mg kits, with an ultimate completion date of August 6, 2025. This non-set-aside award reflects a competitively awarded transaction for pharmaceutical supply to support federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for military and veteran healthcare systems through...
- The Defense Logistics Agency awarded a $23,165.02 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Lupron Depot-Ped 11.25 mg kits. The contract is unclassified as a set-aside and will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 1, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded a delivery order valued at $5,632.97 to AmerisourceBergen Drug Corp for the supply of Lupron Depot-PED 7.5 mg kits under a firm fixed price contract. The award, issued on August 1, 2025, with an ultimate completion date of August 4, 2025, represents a competitively awarded non-set-aside procurement. Performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $7,828.41 by the Defense Logistics Agency's Medical Supply Chain to supply Lupron Depot-PED 15 mg kits. The contract is a firm fixed price delivery order with no set-aside designation, issued on September 3, 2025, and scheduled for ultimate completion by September 4, 2025. Performance will take place at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under...
- The Defense Logistics Agency awarded a delivery order valued at $7,091.79 to AmerisourceBergen Drug Corp for Lupron Depot-Ped 11.25 mg, a three-month pharmaceutical supply, on September 17, 2025. This non-competitive delivery order carries a firm fixed price and is scheduled for completion by September 18, 2025, with fulfillment occurring at the vendor's Conshohocken, Pennsylvania facility. Lupron Depot-Ped is a leuprolide acetate formulation commonly used in pediatric endocrinology for treating...
- SPE2DB25D3002Indefinite Delivery Contract
- SPE2DB25D3002-SPE2DB25FLRLQDelivery Order
The Defense Logistics Agency awarded a $8,190.37 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Lupron Depot-Ped 15 mg kits on September 16, 2025, with an ultimate completion date of September 17, 2025. This non-set-aside award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026. The product will be delivered to AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. Lupron Depot-Ped is a specialized pediatric pharmaceutical used for treating precocious puberty and other endocrine conditions, reflecting the Defense Logistics Agency's critical role in supplying pharmaceutical products to military and veteran healthcare systems. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has demonstrated significant capability in federal medical procurement through its extensive portfolio of delivery orders with the Defense Logistics Agency. The parent IDC vehicle enables the contractor to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order exemplifies the company's versatility in fulfilling federal medical supply needs through competitively awarded contracts with firm fixed pricing across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.2k | 9/16/25 |